Package 0115-1676-08

Brand: alendronate sodium

Generic: alendronate sodium
NDC Package

Package Facts

Identity

Package NDC 0115-1676-08
Digits Only 0115167608
Product NDC 0115-1676
Description

30 TABLET in 1 BOTTLE (0115-1676-08)

Marketing

Marketing Status
Marketed Since 2008-02-06
Brand alendronate sodium
Generic alendronate sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1", "openfda": {"upc": ["0301151681347", "0301151679344", "0301151676084", "0301151678088", "0301151680081"], "unii": ["2UY4M2U3RA"], "rxcui": ["904396", "904405", "904419", "904425", "904431"], "spl_set_id": ["c23fb7fe-c6b9-4f77-bde7-992222b589d3"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0115-1676-01)", "package_ndc": "0115-1676-01", "marketing_start_date": "20080206"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (0115-1676-08)", "package_ndc": "0115-1676-08", "marketing_start_date": "20080206"}], "brand_name": "Alendronate Sodium", "product_id": "0115-1676_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1", "dosage_form": "TABLET", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "0115-1676", "generic_name": "Alendronate Sodium", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alendronate Sodium", "active_ingredients": [{"name": "ALENDRONATE SODIUM", "strength": "5 mg/1"}], "application_number": "ANDA075710", "marketing_category": "ANDA", "marketing_start_date": "20080206", "listing_expiration_date": "20261231"}